Geron Corp
NASDAQ:GERN
Geron Corp
Revenue
Geron Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Geron Corp
NASDAQ:GERN
|
Revenue
$517k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$29.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
19%
|
See Also
What is Geron Corp's Revenue?
Revenue
517k
USD
Based on the financial report for Mar 31, 2024, Geron Corp's Revenue amounts to 517k USD.
What is Geron Corp's Revenue growth rate?
Revenue CAGR 10Y
-6%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Geron Corp have been 15% over the past three years , -9% over the past five years , and -6% over the past ten years .